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Hydrogen peroxide is a membrane-permeable reactive oxygen species (ROS) and a 
neuromodulator. Here, we enhanced the electrochemical detection of hydrogen peroxide by 
modifying a carbon-fiber microelectrode by dip-coating in slurry consisting of graphene, a 
conductive material with a honeycomb structure, and electrochemically depositing Nafion, a 
fluoropolymer. Morphological characterization of the modified electrode by scanning electron 
microscopy (SEM) revealed a fine coating of Nafion/graphene at the electrode surface and 
elemental mapping by energy dispersive X-ray spectroscopy indicated the presence of oxide 
groups, characteristic of graphene. Flow injection analysis of hydrogen peroxide using this 
modified electrode revealed a 5.3-fold increase in the oxidation signal compared the unmodified 
electrode. Moreover, the electrode kinetics were similar to those observed with bare carbon-
fiber microelectrodes. These results suggest that this electrode may be useful for detection of 
transient hydrogen peroxide concentrations in biological systems.   
Post-chemotherapy cognitive impairment (PCCI), also known as ‘chemo brain’, is a 
decline in cognitive function experienced by patients who have undergone chemotherapy 
treatment. Recent studies have shown that up to 30% - 70% of patients who receive 
chemotherapy treatment suffer from a general decline in complex problem solving, memory, 
learning, and motor function. Previous studies in our group have revealed that dopamine 
release and uptake, evoked in the striatum by electrical stimulation and measured with fast-scan 
cyclic voltammetry at carbon-fiber microelectrodes (FSCV), are impaired as a result of 
chemotherapy treatment. Although the reasons underlying this decrease in release are not 
clear, it is possible that terminals may be damaged by ROS. Hydrogen peroxide is an important 
ROS that has the potential to not only cause cellular damage, but also is a participant in the 
regulation of dopamine (DA) release. It is also known to be an inter- and intra-cellular signaling 
molecule. In the striatum H2O2 is generated from glutamatergic AMPA receptor activation in 
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medium spiny neurons. H2O2 can inhibit DA neuron firing via activation of ATP sensitive K+ 
(KATP) channels. Furthermore an imbalance of H2O2 generation and metabolism can cause 
neurodegeneration. To investigate the role of hydrogen peroxide in chemo brain, we measured 
sub-second changes in hydrogen peroxide levels with FSCV in striatal brain slices from rats 
receiving chemotherapy and Saline treated rats.  We utilized two common chemotherapeutic 
agents, Carboplatin and 5-fluorouracil (5FU). We found that, upon treatment of slices with 
mercaptosuccinate, an inhibitor of glutathione peroxidase, the frequency of occurrence and the 
magnitude of transient increases in hydrogen peroxide levels were greater in carboplatin-treated 
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                                                               CHAPTER 1  
Introduction 
1.1 Importance of detecting neurotransmitters and neuromodulators in the brain 
The human brain contains approximately 100 billion neurons that communicate by 
transmission of electrical and chemical signals1. Although specific structural configurations vary, 
neurons signal other neurons and cells by release of chemicals through projections called axons 
and receive chemical signals through dendrites, which also project from the cell bodies (soma). 
The gap between an axon terminal of the presynaptic neuron and the dendrites of the post 
synaptic neuron is called a synapse and chemical communication across synapses is called 
synaptic transmission. When a chemical signal is received, neuronal cells are activated and an 
action potential is generated. This action potential propagates along the axon to the axon 
terminal where small vesicles filled with neurotransmitters are located. These vesicles are 
stimulated by the action potential and the neurotransmitters are released to the extracellular 
space1.This whole process is called exocytosis. The released neurotransmitters bind to the 
neurotransmitter receptors on the surface of another neuron, passing the chemical message. 
Hence, neurotransmitters are essential for neuronal communication.2  
Neurotransmitters are chemicals that promote communication among the brain’s billions 
of nerve cells. Dopamine, for example, plays significant roles in many physiological or 
neurodegenerative conditions, including Parkinson’s disease,3 Huntington’s disease,4 and 
multiple sclerosis.5 Often,  in these and other conditions, neurotransmitter release, especially 
that of dopamine, are impaired. Hence, it is essential to study the chemical dynamics of 
neuroactive molecules to understand the mechanisms underlying the neurodegenerative 
disease states. Another neurochemical, hydrogen peroxide, is a reactive oxygen species (ROS)  
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6, 7 that has also been implicated as neuromodulator6 and has been shown to exhibit control 
over dopamine release at presynaptic terminals.  
Neurotransmitter and neuromodulator levels may be quite low. For example, basal 
concentrations of DA in the striatum are around 10-30 nM.8-10 Therefore, sensitive analytical 
methods, capable of measuring rapidly changing concentrations of these chemicals, are needed 
for their analysis in order to resolve details of neuronal function. Electrochemical methods, such 
as amperometry, various potential pulse methods, and cyclic voltammetry that may be well 
suited for this purpose, have been applied to monitoring neurotransmitter fluctuations in living 
tissues11-14. In these methods the oxidation or the reduction of the neurotransmitters are 
detected at an electrode. Of these methods, background-subtracted, fast-scan, cyclic-
voltammetry at carbon-fiber microelectrodes (FSCV) have proven useful because it affords 
researchers with micron-scale spatial resolution, millisecond temporal resolution, and good 
chemical selectivity.15  
In this work, we used FSCV to measure hydrogen peroxide (H2O2), an important 
membrane permeable reactive oxygen species (ROS) and a neuromodulator that has been 
shown to function in inter- and intra-cellular signaling. As an example, H2O2 modulates locally 
evoked dopamine release in terminals of the brain striatum by interaction with ATP sensitive K+ 
channels located on presynaptic dopamine terminals
6
. The remainder of this chapter focuses on 
methods used to electrochemically measure molecules in the brain. Next, modifications to 
carbon-fiber microelectrodes aimed at enhanced limits of detection are briefly addressed. 






1.2 Electrochemical methods commonly used in neurotransmitter measurements 
1.2.1 Constant Potential Amperometry at Carbon-fiber microelectrodes 
In constant potential amperometry, the electrode is held at a steady potential (holding potential), 
and any electroactive molecule at the electrode surface will be oxidized or reduced, thereby 
producing a faradaic current, which is plotted against time. From those current vs. time plots, 
the total number of electrons transferred can be determined by integration of the current (Q) 
over the time period at which the peak was registered. In accordance with Faraday’s Law (see 
below), the total number of electrons is directly proportional to the number of molecules (N) 
electrolyzed at the electrode surface.16, 17  
𝑄 = 𝑛𝑁𝐹  
                                                             Faraday’s Law (1) 
Where, F is the faradays constant (96,485 Cmol-1 ), n is the number of electrons transferred. 
Because constant potential amperometry avoids complications associated with scanning 
the potential, temporal resolutions of one ms are routinely used when combining this technique 
with carbon-fiber microelectrodes. This outstanding temporal resolution allows real-time 
measurements that can resolve the time course of exocytosis release events. For example, 
constant potential amperometry has been used to determine that 30,000 molecules per vesicle 
are released from adrenal chromaffin cells.13, 18 Nevertheless, the principle drawback of 
amperometry is lack of chemical selectivity; hence, it is not well suited for measurements 
containing complex mixtures of electroactive species, such as those present in the brain. 
Another approach capable of obtaining high-temporal resolution measurements, while at the 
same time providing additional chemical information of the chemical measured, is FSCV.   
1.2.2. Fast-scan cyclic voltammetry at carbon-fiber microelectrodes (FSCV) 
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1.2.2.1 Introduction.  
As stated previously, although amperometry has outstanding temporal resolution, it lacks 
chemical selectivity. Therefore, because the brain mixture of electroactive species is so 
complex,amperometry is not well-suited to selectively measure neurotransmitter/ 
neuromodulator release in this environment. For this purpose, we used fast-scan cyclic 
voltammetry (FSCV) at carbon-fiber microelectrodes. This technique provides sub-second 
temporal resolution and good chemical selectivity in that a cyclic voltammogram (CV), which 
serves as a signature for a given chemical species, is produced. However, before discussing 
the details of FSCV, we first discuss general aspects of voltammetry. 
1.2.2.2 Voltammetry  
Voltammetry became popular among scientist with the invention of the polarography in 1922 by 
Jaroslav Heyrovsky. In Voltammetry, analysis of the analyte involves measuring the current flow 
(i) while applying a potential (E) to the electrode surface. Potential is varied and the current is 
monitored over a time period. Analytes are oxidized or reduced at the electrode surface, and the 
resulting faradaic current response is measured. A primary advantage of voltammetry is that it 
provides excellent sensitivity and a large,useful linear range. In conventional voltammetry using 
macroelecrodes , a three electrode system (see Figure 1), consisting of a working, counter, and 




                             Figure 1. Schematic diagram of three electrode system 
 
This arrangement has the advantage of eliminating IR drop, which is the decrease in potential 
applied to the cell that occurs due to the resistivity of the chemical environment (R). This 
phenomenon is dependent upon Ohm’s law, E = IR, where E is applied potential (in V), I is 
current (in mA), and R is the resistance of the chemical environment. At high currents and 
resistances (MΩ), the amount of IR drop is sufficient to distort the current trace of a 
voltammogram because as applied potential becomes greater, the difference between applied 
potential and actual potential applied to the cell becomes greater.19 As will be discussed below, 
despite the brain being a highly resistive environment, a two-electrode system can be used for 
FSCV since the magnitude of the currents measured is on the order of nA.  
 
1.2.2.3 Cyclic voltammetry  
Cyclic voltammetry is used in a variety of applications, including compound identification in 
general research, environmental, and neuroscience. This technique can provide useful 
information such as electrode properties, reaction kinetics and quantitative measurements of a 
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number of substances. In cyclic voltammetry, the applied potential is scanned to a different 
selected potential over a specified time interval and then scanned back. These cycles are 
repeated continuously as needed. When initially sweeping to a more positive potential, the 
analyte is oxidized. When scanning back to the original potential, if the reaction were reversible, 
the oxidation product will be reduced. The resulting current from the redox events during the 
cyclic sweeping is plotted against the applied potential to obtain a cyclic voltammogram (CV). 
The voltammogram of an analyte has a characteristic CV with a unique shape19. Hence, this 
method can be applied for the identification of a single species among several other substances 
without the requirement of further separation.  
Cyclic voltammetry also allows determination of electrochemical reversibility by 
inspection of CVs. For a reversible electrochemical reaction, the criteria are as follows: (1) the 
difference in potential (E) at which the oxidation and the reduction peaks occur should be less 
than 0.058 V/n, where n is the number of electrons transferred in the redox reaction; (2) 
Oxidation and reduction current  should be very close.20 Electrochemically reversible reactions 
obey the Nernst equation.16  
 
1.2.2.4 Fast Scan Cyclic Voltammetry at carbon-fiber microelectrodes 
Fast Scan Cyclic Voltammetry (FSCV) is a variation of cyclic voltammetry and a powerful 
electroanalytical technique for measuring sub-second changes in neurotransmitter levels.15 This 
electrochemical method was developed in 1980s by Jullian Miilar and colleagues in London.
21, 22
 
Compared to cyclic voltammetry, FSCV utilizes a much faster scan rate (up to 1 x 106  V/s). By 
applying a fast scan rate, voltammograms can be acquired rapidly within milliseconds.23 FSCV 
provides good temporal resolution: 100 ms per CV as applied in our work. FSCV at carbon-fiber 
microelectrodes has been successfully used for the detection of neurotransmitters in biological 
systems. In FSCV, a triangular wave form is applied to the electrode at a high scan rate and the 
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electroactive species are oxidized and reduced at the electrode surface. The resulting faradaic 
current is measured.  
 
 
Figure 2. (A) Wave form applied, (B) Back ground subtracted cyclic voltammogram for DA. 
Holding potential at the electrode surface is insufficient to oxidize DA. Then the potential is 
linearly ramped to an oxidizing potential (1.3V) and back to -0.4V at a high scan rate (400V/s). 
DA is oxidized in the positive sweep in to dopamine-o-quinone and reduced back in to DA in the 
negative sweep. This process is shown in Figure 3. Electron flux is measured as current. 
Furthermore, resulting current is directly proportional to the number of molecules that undergo 
oxidation.  
 
When applying fast scan rates, a large background current arises from the charging of the 
electrical double layer which is proportional to the capacitance of the electrode.  To resolve this 
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problem, background current is subtracted. Figure 3 illustrates how the background subtraction 
is achieved.   
 
 
Figure 3. Back ground subtraction to obtain the cyclic voltamogramm. Substracting the back 
ground signal from the back ground and the dopamine signal 
                 The resulting CV provides a chemical signature used to identify the species 
detected.24, 25 Calibration factors obtained from standards of known concentrations are used to 
convert the peak currents in to concentrations. Due to the advantage of chemical selectivity, 
FSCV has been widely used in vitro and in vivo to detect a vast number of electroactive 
biological compounds such as dopamine, 5-HT, serotonin and norepinephrine.26-28 Dopamine is 
the most common biogenic amine which is studied using FSCV; however, other electroactive 
species have been measured. These include serotonin,29 norepinephrine, adenosine,30 and 
hydrogen peroxide.31 
 
(A) Background and Dopamine       (B) Background     
(C) Dopamine (obtained by subtracting B from A) 
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Carbon fiber microelectrodes (CFMEs) were invented in late 1970s by Francois Gonon 
and colleagues32, 33. Most current biological research with electrochemical methods is done with 
carbon-fiber microelectrodes due to their many beneficial properties including biocompatibility, 
inert nature, low cost, high tensile strength and wide potential window23, 34, 35. These electrodes 
are fabricated using carbon fibers which are typically on the order of 5-10 µm in diameter, 
although larger and smaller diameters may be used. Generally speaking, fabrication in our 
laboratory is simple: single carbon fibers (7 µm in diameter) are aspirated into glass capillaries 
and pulled using a heated coil puller and trimmed with a scalpel to the desired length. The 
carbon-fiber is sealed by dipping in an epoxy resin. Excess resin is removed by dipping the 
electrodes several times in toluene and then cured by baking in an oven for 1 hour at 100 °C. 
An example is shown in Figure 3. The electrodes are back filled with 0.5 M potassium acetate in 
order to establish an electrical connection. Different geometries of microelectrodes include disk, 
elliptical, needle, double barrel and band electrodes, and each has it’s own unique 




Figure 4. A scanning electron microscopy image of a carbon fiber microelectrode 
As mentioned previously FSCV coupled with CFMEs is been used for years to 
distinguish and identify readily oxidizable biological compounds such as dopamine and 
serotonin. Specifically, this electroanalytical method is ideal for monitoring the chemical 
dynamics of neuroactive molecules and other electroactive molecules. Hence, this is an 
appealing analytical tool for detecting a wide range of species in the brain.  Waveforms may be 
optimized for detection of different chemical species. For example dopamine, a catecholamine 
commonly detected using FSCV at CFME28, 37, is often monitored by ramping the potential from 
-0.4 V to 1.3 V and then back to -0.4 V (Figure 4b). 
In addition, non-electroactive species also can be detected using FSCV couple with 
modified CFMEs. Often CFMEs are coated with an enzyme to convert the non-electroactive 
species to an electroactive species.38 Oxidase enzymes are commonly used for this process, 




as the final product and can be electrochemically oxidized and detected on the electrode 
surface.31, 39 For instance, glucose is converted to H2O2 by the enzyme glucose oxidase. 
Detection of H2O2 using FSCV coupled with CFMEs will be explained in more depth in Chapter 
2. 
1.3 Modified electrodes 
In general, modified electrodes can be divided in to several categories, including those with 
derivatized surfaces, polymer coated electrodes, and functionalized electrodes.
40
 Modified 
electrodes often take advantage of enhanced electron transfer kinetics. Moreover, modified 
electrode surfaces may provide several other benefits, including improved sensitivity due to 
increased surface area, improved selectivity toward the analyte of interest due to the presence 
of immobilized functional groups and dopants, and fast diffusion kinetics.40, 41 Examples of 
materials used for electrode modifications include nanostructured materials and substances 
including nanoparticles, carbon nanotubes (CNTs), graphene and its derivatives, metals, alloys, 
inorganic substances and polymers30, 40, 42-44. After modification, it is critical to characterize the 
electrode surface to ensure proper modification. Techniques that have been used include 
Raman spectroscopy, scanning electron microscopy (SEM), and X-ray photoelectron 
spectroscopy (XPS).45 Additionally, electrochemical characterization methods, including cyclic 
voltammetry46 and FSCV,31, 47 have been used. In this work, carbon-fiber microelectrodes are 
modified with graphene. These modifications are discussed in more detail in Chapter 2.  
 
1.4 Overview. 
The next two chapters discuss developing a graphene oxide/Nafion modified carbon-
fiber microelectrode with enhanced sensitivity for H2O2 detection (Chapter 2) and probing H2O2 
levels in chemotherapy treated rats (Chapter 3). Chapter 2 describes the fabrication process 
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and the characterization of the GO/Nafion CFME, as well as application of this sensor to 
measuring transient H2O2 concentrations in brain slices. Chapter 3 addresses post 
chemotherapy cognitive impairment (PCCI), also known as chemo brain. The symptoms of 
PCCI, plausible causes of PCCI, and measurements of H2O2, are also discussed. Finally, future 
directions and conclusions are presented in Chapter 4. 
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Chapter 2: A graphene modified electrode for measuring hydrogen 
peroxide  
1. Introduction 
1.1 Hydrogen peroxide.  
Hydrogen peroxide (H2O2) is a reactive oxygen species and membrane-permeable 
neuromodulator produced naturally in cells. It is among the most stable ROS, with a half-life of 
10-5 sec,1 and hence plays a crucial role in numerous physiological processes, both inter- and 
intra-cellularly.  For example, H2O2 signaling plays a role in the local regulation of DA release in 
the striatum in a mechanism first involving the activation of AMPA receptors, located on medium 
spiny neurons (MSNs), by glutamate. This activation is followed by production of H2O2 in the 
mitochondria of MSNs and its subsequent diffusion to K+ATP channels, located on dopaminergic 
terminals. These channels are then modified to allow the passage of potassium ion (K+) into the 
cell, thereby inhibiting dopamine release.2 In addition to its role as a neuromodulator, H2O2 has 
practical uses. For example, enzymatically generated H2O2 has been used as a reporter 
molecule generated by oxidase enzymes, such as glutamate oxidase and glucose oxidase,3, 4 at 
enzyme-modified microelectrodes that are used to monitor non-electroactive species, such as 
glutamate and glucose.4 In its capacity as an ROS, H2O2 forms hydroxyl radicals that can 
irreversibly alter the structure of DNA, lipids, and proteins, resulting in pathological oxidative 
stress, neuronal degeneration, and aging.4-6 Therefore, given its biological importance, the 
quantitative measurement of H2O2 levels in tissues, especially those that are richly oxygenated 






Cellular Production of Hydrogen Peroxide 
Although H2O2 may be formed by multiple mechanisms, three of the most prominent 
modes of formation include mitochondrial respiration and metabolic reactions involving either 
monoamine oxidase (MAO) or NADPH Oxidase (Nox).2, 7  
Mitochondrial Respiration. Mitochondrial respiration is thought to be the primary production 
source of H2O2 that participates in the modulation of dopamine.  Here, O2 is reduced to form the 
superoxide ion and it is converted to H2O2 by superoxide dismutase (SOD). Four sub complexes 
are included in the mitochondrial electron transport chain (I- IV). Super oxide ion (O2 
.- 
) is  mainly 
generated in complex I and III.8  
 
Scheme 1.   Generation of H2O2   in the respiratory chain 
Monoamine Oxidase. MAO controls monoamine levels by catalyzing oxidative deamination of 
monoamines.9, 10 Monoamine neurotransmitters are involved in cognitive function. Hence, 
excessive levels of monoamines can lead to several neurological disorders. MAO is essential in 
controlling the monoamine levels.  This enzyme, which is abundant in the striatum as well as 
other brain regions that have high concentrations of catecholamines, catalyzes the deamination 





Scheme 2. Deamination of DA10  
 
NADPH Oxidase. NADPH Oxidase (Nox) enzymes catalyze the one electron reduction of O2 to 
form super oxide ion and subsequently form H2O2. Nox can be found in striatum and a variety of 
signaling pathways11-14 Moreover, enzymes in mitochondria such as NADPH, Xanthine Oxidase 
(XO) and Cytochrome p-450 reductase can convert anthracyclines to quinone or semiquinone 
through one electron reduction of the quinone moiety. Resulting semiquinones can be converted 
back to quinone by reacting with O2 producing super oxide anion which is eventually converted 
in to H2O2.  Some chemotherapeutic drugs such as doxorubicin can increase ROS production 
via this process.11 
 
   
1.2 Electrodes for the detection of hydrogen peroxide 
Historically, platinum electrodes have been useful in the detection of H2O2 given its ability resist 
chemical reactions and oxidize H2O2 at low applied potentials.
15
 For instance, George Wilson 
and coworkers have studied electrochemical oxidation of H2O2 on Pt and Pt/Ir electrodes with 
amperometry, in which the electrodes were held a constant potential of 0.65 V vs Ag/AgCl 
reference electrode.4, 16 More recently, FSCV at bare carbon-fiber microelectrodes has been 
used to detect H2O2 in brain tissues.
2 This adaptation has provided a method to monitor 
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Equation 1. Irreversible oxidation of H2O2 
 
    Despite the utility of these electrode materials in detecting H2O2, progress is hampered by the 
fact that extracellular levels are low (in the µM range), making it difficult to detect without 
pharmacological intervention, such as addition of mercaptosuccinic acid, a peroxidase inhibitor. 
For this reason, we explored electrode modifications that might improve limits of detection for 
H2O2. Several types of modifications to carbon-fiber microelectrodes have been used to 
enhance the detection of various analytes. For example, Nafion, a negatively charged, water 
permeable fluoropolymer that hinders access of anions to the electrode surface,18 has been 
used to improve the detection of catecholamines while suppressing interference from negatively 
charged species, such as ascorbate.18, 19 Other modifications have also been combined with 
Nafion and other polymers to selectively improve the signal. For example, carbon nanotubes, in 
conjunction with other polymers, such as poly (3,4ethelenethiophene)PEDOT,20 have been 
adsorbed to the surface to enhance detection of dopamine and octopamine in fruit flies.21   
 
1.3. Electrode modification with graphene oxide 
 While the most common carbon-based modifications used in the past have been carbon 
nanotubes (CNT) and multiwalled carbon nanotubes (MWNT), graphene oxide (GO) has gained 
recent attention due to beneficial characteristics, including  electrical, conductivity, thermal, 
mechanical and chemical properties,22, 23 that enhance detection of specific analytes.20,24-26 GO 
possesses a 2-dimensional honeycomb structure consisting of sp2- and sp3-hybridized carbon 
atoms functionalized with epoxide, hydroxyl, carbonyl and carboxylic (Fig. 1).22,27 These 
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structural features provide several advantages. First, the presence of functional groups facilitate 
the dispersal of GO in water and many organic solvents. Also, oxygen molecules in GO facilitate 
immobilization of the nanoparticles on electrode surfaces.27, 28 Furthermore, its 2D lattice 
structure provides a large platform for loading nanoparticles which effectively increases the 
surface area of the microelectrode. Finally, GO can be prepared easily from graphite using the 
Hummers method and GO can be considered as a precursor for graphene and reduced 
graphene oxide (rGO). Recently, graphene modified microelectrodes have been used for the 
detection of dopamine in the brain.20, 26 In this work, we have modified carbon-fiber 
microelectrodes by dip-coating in a graphene oxide slurry, followed by electrodeposition of 
Nafion onto the surface. We have found that this modification improved the sensitivity to H2O2 
more than five-fold while having little effect on the detection of dopamine and serotonin. This 
electrode modification could improve the capability of selectively detecting H2O2 in the brain.   
                                   







2. Experimental Procedures 
2.1 Chemicals 
Graphene oxide (2mg/ml) in H2O, lot# 763765, 25ml  and  all other chemicals were purchased 
from Sigma – Aldrich (St. Louis, MO, USA) and used as received, unless otherwise noted. 
Physiologically buffered artificial cerebrospinal fluid (aCSF) buffer solution, used in all flow 
injection analysis measurements, consisted of (in mM): 126 NaCl, 2.5 KCl, 25 NaHCO3, 1.2 
NaH2PO4, 2.4 CaCl2, 1.2 MgCl2, 20 HEPES and was adjusted to a pH of 7.4. All aqueous 
solutions were prepared with ultra-pure MilliQ (18.2 MΩ) water. 
2.2 Fabrication of GO/Nafion/CFME 
Carbon-fiber microelectrodes were made in-house. A 7 µm carbon fiber was loaded into glass 
capillaries by aspiration (4 in, 1.2Cmm OD; A-M System, Inc. Carlsberg, WA, USA) and 
capillaries were pulled using a heated coil puller (Narishige International USA, East Meadow, 
NY, USA). Carbon-fiber tips were then cut, with a scalpel, so that the exposed electroactive 
surface projected 50 µm from the end of the glass seal. Electrodes were sealed using an epoxy 
mixture of 0.24 grams EPI-CURE 3234 Curing Agent and 2.00 grams EPON Resin 815C. 
Excess resin was removed by dipping the electrodes several times in toluene.  Finally, the 
electrodes were baked for 1 hour at 100 °C. The electrodes were back filled with 0.5 M 
potassium acetate in order to establish an electrical connection. Prepared CFMEs were 
modified as follows. First, CFMEs were dip-casted with 1 mg/ml GO suspension and air dried 
over night to prepare the GO/CFME. Ultra-pure Milli-Q water (18.2 MΩ) was used in preparation 
of 1 mg/ml GO from the 2 mg/ml GO commercially provided suspension.  Second, 5% Nafion 
solution in methanol was electrochemically deposited on the GO casted carbon fiber 




2.3 Characterization of the electrode surface 
Electrode surface characterization was carried out in the University of Kansas Microscopy and 
Analytical Imaging Laboratory. The surface of the modified carbon-fiber was characterized using 
a VERSA 3D dual beam Scanning electron microscope FEI (Abingdon, Oxford Shire, United 
Kingdom). Moreover, composition of the modified electrode surface was studied using (EDX) 
energy dispersive X-ray spectroscopy (Oxford Instruments X- MaxN) 10keV, resolution width 
512 pixel, resolution height 352 pixel, Magnification 30,000X. 
 
2.4 Flow cell analysis for the modified electrodes.  
The electrochemical characteristics of the modified electrode, referenced against a 
Ag/AgCl electrode, was studied by flow injection analysis at room temperature. The works tation 
consisted of a Chem-Clamp potentiostat (Dagan Corp., Minneapolis, MN) interfaced with a 
personal computer by a locally constructed breakout box. Tar Heel Software (M. Heien and 
R.M. Wightman, University of North Carolina, Chapel Hill) was used. Figure 2 shows a 
schematic diagram of the flow injection analysis system. A 6-port Rheodyne-type HPLC valve 




Figure 2. Schematic diagram of the injection analysis system (where, WE = working electrode, 
RE = reference electrode  
 A syringe pump supplied the aCSF buffer from a 50 mL syringe at a flow rate of 1 ml/min 
across the working electrode. Analyte was introduced to the working electrode through a sample 
loop with a Rheodyne-type valve. Analyses were performed separately for hydrogen peroxide 
(H2O2), dopamine (DA), and serotonin (5-HT). During each injection, a triangular waveform of -
0.4V to 1.4V to -0.4V was applied to the working electrode at a scan rate of 400 V/s and an 
update rate of 10 CVs/s. A background CV, obtained by averaging 10 CVs collected prior to the 
injection of analyte, was subtracted from the entire set of CVs collected for each file (20 to 30 s 
in duration). This background subtraction process eliminates the large non-faradaic charging 
current observed at high scan rates.30 During collection, data were treated with a 3 kHz low-
pass filter (from the Dagan Chem-Clamp). Analyzed color plot data were treated with a 2 kHz 
low-pass filter in the Tar Heel data analysis program.  
 
2.5 Statistics 
Statistically significant differences were determined using student’s t tests and ANOVA tests 
with post hoc analysis. A value of p < 0.05 was used to delineate statistical significance. The 
limit of detection (LOD) was defined as three times the noise (S/N = 3) and the limit of 
quantitation was defined at ten times the noise (S/N = 10). GraphPad Prism 5.1 (GraphPad 








3. Results and Discussion 
3.1 Characterization of electrode surface (Bare Vs Modified) 
The morphology of the modified carbon fiber was investigated by scanning electron microscopy 
(SEM). Figure 3A shows an SEM image of an unmodified carbon-fiber whereas Figure 3B 
shows an SEM image of a carbon-fiber microelectrode modified with GO/Nafion. As can be 
seen, the coated electrode appears to have a thin film of Nafion and GO adsorbed to the 
surface. To confirm further the presence of GO, energy dispersive X-ray spectroscopy (EDX) 
analysis was also performed on the electrode surfaces. This method of analysis identifies the 
presence of functional groups by ejecting inner shell electrons, induced by exposure to an X-ray 
beam, and the subsequent release of X-rays from the sample. The energy of the emitted X-ray 
is characteristic of the exposed element. 
Figure 3.  SEM image of unmodified carbon-fiber microelectrode (A) and GO/Nafion coated 
carbon-fiber (B). Magnification: 50,000X. 
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Figure 4. (A) EDX spectrum of bare CF (B) EDX spectrum of GO/Nafion CF. Labels: C, 
carbon; O, oxygen; F, fluorine; Al, aluminum; Si, silicon. 
 
Resulting spectra for both the bare and modified electrode are shown in Figure 4. In the 
case of the bare electrode (Figure 4A), a single, large peak was observed at an intensity of 
about 360 cps/keV, indicating primarily the presence of carbon. On the other hand, analysis of 
the modified electrode (Figure 4B) revealed multiple peaks. The carbon peak was present at 
much greater intensity (55,000 cps/keV). Additionally, smaller peaks for oxygen (500 cps/keV) 
and fluorine (650 cps/keV) were also present. These peaks likely indicate the presence of 
graphene oxide, which contains carbon and oxygen groups, and also Nafion, which contains 
carbon and fluorine. Although it is not clear why peaks at ~1.6 and ~3.1 are present, it is likely 
they arise from Al and Si contamination. Collectively, these results suggest that graphene oxide 
and Nafion were  effectively immobilized on the surface of the electrode.                
 
3.2. Electrochemical analysis of modified electrodes 
The next step was to electrochemically characterize the modified electrode for 
comparison with the bare carbon-fiber microelectrode. A flow injection analysis system, in which 
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the microelectrodes were exposed to analyte by injection through a sample loop under control of 
a Rheodyne-type valve, was used. A sample file, obtained by a single injection of H2O2 at a 
concentration of 10 µM, is shown in Figure 5A.  The CV reveals an irreversible oxidation 
reaction occurring, with the oxidation peak occurring at about +1.2 V on the backsweep,32 after 
the potential had already reached the maximum of +1.4 V. A similar peak was observed when 
measuring H2O2 with bare carbon-fiber microelectrodes Figure 5B.
31 The signal increased from 
10 to 90% in 2 ± 0.2 seconds for the modified electrode, compared to 2.5 ± 0.3 seconds for the 
bare electrode (p > 0.05, student’s t-test, n = 4,). Thus, the modification appears to not 
significantly alter the kinetics of the oxidation reaction.         
 
Figure 5. Detection of H2O2 oxidation in a flow injection analysis system (A) with GO/Nafion 
CFME , (B) with bare CFME.  
 
The oxidation currents and cyclic voltammograms of bare electrodes, Nafion-coated 
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(Figure 6). Oxidation currents obtained for the modified electrode were enhanced 5.3 fold 
compared to the bare carbon-fiber microelectrode (n = 6 for bare and modified, n = 3 for Nafion, 
ANOVA p< 0.05). An irreversible oxidation peak was observed at about 1.2 V,31 for the bare and 
Nafion-coated carbon fiber micro electrodes. The oxidation peak (Ep) for the modified electrode 
was shifted towards a positive potential (about +0.1 V) on the backsweep. 
 
 
Figure 6. (A) Comparison data for oxidation current for H2O2 obtained with bare, Nafion coated 
and GO/Nafion coated CF micro electrodes. (B) Comparison cyclic voltammograms. Oxidation 
current for H2O2 is significantly increased 5.3 fold enhancement 
 
 Representative data for the electrochemical characteristics of the modified electrode for 
dopamine and serotonin are shown in Figure 7. Obtained CVs were very similar to those 
obtained with bare carbon-fiber electrodes. The dopamine oxidation peak occurred at +0.6V 
whereas the reduction peak occurred at -0.2V. For serotonin, the oxidation peak was observed 
around +0.8V and the reduction peak was observed -0.15V. Moreover, for Dopamine, a 2.1 fold 















































For 2 µM, Serotonin (n=3), t-test, 
P>0.05, not significant 
 
* 
4 electrodes, t test p<0.05). However, current enhancement for the serotonin was not increased 












Figure 7. Electrochemical response of the modified electrode towards (A) dopamine (3 µM) and 
(B) serotonin (2 µM).      
 
3.3. Stability  
For obtaining consistent data the currents obtained with the modified electrode should not 
change with the time. Stability of the Current for the modified electrode was studied over one 
hour for 5 µM H2O2. This time frame is generally consistent with the amount of time needed to 
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obtain a set of measurements in a brain slice. The current was found to be stable for the 
GO/Nafion CFME during this time (Figure 8).  
Figure 8. Stability test. Electrode response to injection of 5 µM H2O2 was measured over a one 
hour period. Peak current did not deviate significantly over time. N = 3 electrodes.  
Obtaining a stable current is essential for modified electrodes since most of the time 
modified electrodes can be foul. Modified materials can be delaminate from the electrode 
surface when used in aqueous solutions for a longer time. To prevent electrode fouling and to 
obtain a long lasting electrode, researchers often use conductive polymers such as PEDOT and 
Nafion. In addition to the prevention of electrode fouling these conductive polymers can exclude 
interfering ions.15 For instance, Nafion which is a cationic exchange polymer can exclude 
negatively charged ions.    
    Obtaining a thin coating of these conductive polymers can be controlled by applying a    
potential which is sufficient to oxidize and polymerize the polymer. Moreover, incorporating 
negatively charged GO in to a conductive polymer allows it to be used as an electrode material 


















Calibration curves for detection of H2O2 with bare and modified electrodes is shown in Figure 9. 
For bare electrodes, the current response to increasing H2O2 concentrations was linear up to 
about 100 µM (R2 = 0.99, linear regression), while a deviation from linearity at 50 μM was noted 
for the modified electrode. It is not yet clear why this deviation from linearity occurs. 
Measurements obtained previously with bare carbon-fiber microelectrodes in anesthetized rats 
have measured H2O2 transients at a peak concentration of ~5 μM.
2 This concentration falls 
within the dynamic range of our GO/Nafion modified electrode. It must be mentioned, however, 
that, in the case of certain pathologies, such as global ischemia, H2O2 levels have been 
estimated to climb as high as 100 μM (outside the linear range); in this case, caution should be 






Figure 9.  Calibration curves for modified (A) and bare (B) electrodes. Sensitivity is enhanced by 
3.7 fold n = 3 
  The sensitivities, obtained from the slopes of the lines, were 0.352 nA/µM for the bare 
electrode and 1.33 nA/μM for the modified electrode. The limits of detection (LOD, based on 
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S/N=3) and quantitation (LOQ, based on S/N=10) for the bare electrode was 2500 nM, 8250 nM 
respectively, while that for the modified electrode was 50 nM and 165 nM. Thus, we found that, 
for detection of H2O2, the GO/Nafion treatment provided a 3.7 fold enhancement in sensitivity, 
and substantially improved LOD and LOQ. A similar enhancement sensitivity had previously 

















Figure 10.  H2O2 release plot  for Bare and GO/Nafion CFME(A), H2O2 transients in MCS treated 
and untreated rats with bare and GO/Nafion CFME (B), Decomposition of H2O2 upon the 
introduction of catalase(C). 
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These modifications include the use of graphene oxide with PEDOT for enhanced detection of 
dopamine (880% increase in sensitivity)20 and carbon nanotubes with Nafion (2.3-fold increase 
in sensitivity). Our modified sensor provided roughly a two-fold enhancement in response to 3 
μM dopamine and appeared to give a slightly enhanced response to 2 μM serotonin, although 
not statistically significant. Although the reason behind this selective enhancement of the H2O2 
electrochemical response is not clear, it is possible that H2O2 being smaller and highly diffusible 
compared to dopamine and serotonin, is less impeded in traveling though the Nafion coating.  
 
3.5. Brain slice studies. Given the positive results obtained for the detection of H2O2, our next 
step was to apply this electrode for the measurement of H2O2 in brain slices.
2 Shown in Figure 
10 are data obtained from a striatal brain slice taken from a Sprague-Dawley rat. Figure 10A 
shows a representative H2O2 release plot and CV for bare and GO/Nafion coated electrodes. In 
this case, the slice was treated with MCS to enhance the formation of H2O2 transients. Also, 
results from MCS-treated and untreated slices are summarized in Figure 10B. From these data, 
it is apparent that the GO/Nafion coating significantly enhanced the H2O2 signal in both MCS-
treated (p<0.05, t-test, N = 4 electrodes) and untreated (p<0.05, t-test, N  = 4 electrodes) slices.  
Treatment of the slice with catalase (Figure 10C), an antioxidant enzyme that catalyzes the 
decomposition of H2O2 in to water and oxygen, decreased the current, measured with the 
GO/Nafion electrode, providing positive identification of H2O2. Therefore, we conclude that 
modification of the electrode surface with GO/Nafion improves the ability to detect H2O2 
transients in striatal brain slices.   
3.6 Conclusions 
In this work, we have designed, constructed, and evaluated a novel graphene electrode for the 
detection of hydrogen peroxide. Morphological studies done with SEM revealed the thin coating 
of the GO/Nafion on the carbon fiber surface and the EDX spectrums confirmed the presence of 
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oxygen containing groups. Moreover, flow cell analysis with 10 µM H2O2 revealed that the 
oxidation current for the modified electrode was increased by 5.3 fold compared to the bare 
carbon-fiber micro electrode. Limit of detection of the GO/Nafion CFME was found to be 0.05 
µM compared to 2.5 μM for the bare electrode and the sensitivity was found to be increased by 
3.7 fold. Cyclic voltammograms, obtained using the modified electrode in a brain slice, were 
similar to that of the bare carbon-fiber microelectrodes, except for a ~0.1 V shift in oxidation 
peak to a more positive potential on the backsweep. Currents obtained from the oxidation of 
H2O2 (confirmed by addition of catalase) in brain striatal brain slices without MCS were greater 
when using the GO/Nafion modified electrode compared to the bare electrode, both in the 
absence of MCS and in the presence of MCS.  
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Chapter 3: H2O2 and post chemotherapy cognitive impairment (PCCI) 
1. Introduction  
1.1 Post chemotherapy cognitive impairment  
Approximately 20-30% of cancer patients who have received chemotherapy treatments 
suffer from post chemotherapy cognitive impairment (PCCI), also known as ‘chemo brain.’ PCCI 
is a cognitive syndrome associated with a general decline in cognitive function, memory skills 
and attention deficits.1, 2 Some common symptoms of PCCI include confusion, fatigue, and short 
attention span, difficulty learning new skills, inability to effectively multitask, and taking longer 
than usual to complete routine tasks.3 Although the causes of PCCI are still not clear, recent 
evidence suggests that it may be caused by several mechanisms. These include genetic factors 
such as impaired DNA dysregulation, DNA damage, blood brain barrier (BBB) dysfunction, and 
dysfunction of the immune system.4-6 In addition to these potential factors, alterations in 
neurotransmitter signaling may be impaired by inherent toxicity of several types of 
chemotherapeutic agents, thereby altering brain function.7-10 
      
1.2 Chemotherapy and common chemotherapeutic agents 
 Chemotherapy is a type of cancer treatment in which toxic agents are used to destroy 
cancer cells based on their faster rate of division. Depending on the type and the severity of the 
cancer, chemotherapy can cure/control the cancer or ease the cancer symptoms. Often, 
chemotherapy is used along with surgery, radiation therapy or biological therapy. There are two 
types of chemotherapy treatments neo–adjuvant chemotherapy and adjuvant chemotherapy.  
Neo–adjuvant chemotherapy is used to shrink a tumor before surgery or radiation therapy 
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whereas adjuvant chemotherapy destroys cancer cells that may remain after surgery or 
radiation therapy. Furthermore, chemotherapy is often used to enhance the effectiveness of 
biological therapies in destroying recurrent cancer cells and preventing metastatic cancer 
(spread to other parts of your body). Chemotherapy can be given in several ways including oral, 
intravenous (IV) and injection. Table 1 illustrates the different ways that chemotherapy is 
administered.11, 12 
Table 1. Routes of administration of chemotherapeutic drugs 
Type Description 
Oral 
Chemotherapeutic drug comes in a pill or tablet that the patient 
can swallow 
Intravenous (IV)  Chemotherapeutic drug is placed directly in to a vain 
Injection 
Drug is given by a shot in a muscle in your arm, thigh or hip or 
right under the skin in the fatty part of your arm, leg or belly. 
Intrathecal 
Drug is injected in to the space between layers of tissue that 
cover the brain and the spinal cord. 
Intraperitoneal (IP) Drug goes directly in to the peritoneal cavity. 
 Intra-arterial  Drug is injected directly in to the artery that leads to the cancer. 
Topical  
Chemo drug comes in a cream that the patient can rub on to the 
skin. 
 
Importantly, both dividing and non-dividing cell populations in the CNS are vulnerable to the 
effects of chemotherapeutic agents.
11-13
 The type of chemotherapy drug, dose, and treatment 
schedule depend on the following factors; type of cancer, tumor size and location and the stage 
of the cancer, age and general health, how well the patient can cope with certain side effects, 
other medical conditions and previous cancer treatments. Sometimes a combination of drugs 
(which means you are receiving two or three drugs at the same time) are given to make the 
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treatment effective. There are different types of chemotherapy drugs including Cytoxan, 
Carboplatin, 5-fluorouracil (brand name Adrucil), Doxorubicin (Doxil). 
 
1.3 Possible causes of PCCI  
 As mentioned earlier, PCCI is the chemotherapy related cognitive impairment or 
cognitive dysfunction. Researchers have shown that there can be multiple causes behind the 
cognitive dysfunction that many cancer survivors experience.  Loss of the structure or the 
function of the neurons is called the neurodegeneration. Neurotransmitter signaling can be 
affected by the toxicity of the chemotherapy drugs. It has been discovered that progenitor cells 
and oligodendrocytes in the brain are highly sensitive to some chemotherapy drugs.14 Hence, to 
provide an effective chemotherapy treatment with lesser side effects, it is essential to study the 
mechanism of the neurodegeneration which causes the PCCI. 
 Previous studies done in our group have revealed that dopamine (which is an important 
neurotransmitter for cognitive function) release and uptake in the striatum, evoked by electrical 
stimulation, is impaired as a result of chemotherapy treatment.15 Although the reason for this 
decrease in release is not clear, it is possible that the terminals of the neurons may be damaged 
by reactive oxygen species (ROS). Hydrogen peroxide (H2O2), a well-known ROS that is 
generated in several ways, including as a by-product of mitochondrial respiration, has the 
potential to cause cellular damage. Additionally, H2O2 can act as a neuromodulator for DA.
16, 17 
In this work, we evaluated two chemotherapeutic agents in rats in order to measure their effects 
on H2O2 production.  
1.4 H2O2 as a neuromodulator 
Recent findings have suggested that H2O2 is an inter- and intra-cellular signaling 
molecule as well as a local neuromodulator of the release of dopamine, a neurotransmitter that 
plays a crucial role in motor and cognitive function.17, 18 One way that H2O2 may be generated is 
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by activation of glutamatergic AMPA receptor on medium spiny neurons in the striatum. This 
endogenously produced H2O2 can inhibit DA release by activating the ATP sensitive K
+
ATP 
channels.19 These channels, which are gated by intracellular nucleosides ATP and ADP and are 
found in the plasma membrane and subcellular membranes, are composed of K ir 6.X – type 
subunits and sulfonylurea receptor (SUR) subunits with other additional components.20 KATP 
channel levels are particularly high in the striatum and the substantia nigra (SN) compared to 
other brain regions.19, 21-23 Initial evidence that H2O2 could act as a neuromodulator came when it 
was found that exogenously applied H2O2 decreased the amplitude of evoked population spikes 
in hippocampal slices.24, 25 Many other experiments have been performed to assess the effect of 
H2O2 on evoked DA release in striatal brain slices.  
Figure 1 illustrates the activation of KATP channels by elevated H2O2. It is important to 
note that, under normal conditions, H2O2 levels are tightly regulated by peroxidase enzymes, 
such as glutathione (GSH) peroxidase and catalase,16 both of which catalyze reduction of H2O2 
to water. Endogenous H2O2 levels can be elevated by addition of inhibitors of peroxide 
scavenging enzymes; for example, mercaptosuccinate (MCS), which is an efficient glutathione 




Figure 1.  Schematic diagram depicting the activation of KATP channels via elevated endogenous 
H2O2 by MCS 
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1.5 Detection of H2O2 with FSCV  
As mentioned in the Chapter 1, background subtracted FSCV is an electrochemical 
technique that is well suited for measuring sub-second changes in concentrations of 
electroactive neurotransmitters, such as dopamine and serotonin.27 This method provides good 
selectivity, high spatial resolution, and excellent temporal resolution.28  
  The detection of H2O2 with FSCV has recently been described by Sanford et al.
29, 30  To 
selectively detect H2O2, the waveform is ramped up to +1.4V from a holding potential -0.4V and 
swept back at a scan rate of 400 V/s.16 After background subtraction, the irreversible oxidation 
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Figure 2. A current plot (A) is shown above the corresponding color plot (B). The applied wave 
form was -0.4V to 1.4V to -0.4V (C), and was used to generate the characteristic cyclic 
voltammogram (D) of H2O2. 
Each cycle is repeated every 100 ms, offering sub-second temporal resolution. The procedures 
for FSCV have been described in more detail in Chapter 2. Briefly, the voltammograms are 
unfolded at the switching potential and stacked with respect to collection time. A color plot is 
generated where the Y axis represents the applied potential in V, the X axis represents the 
collection time in seconds and the Z axis represents the current in nA.31 From a color plot a 
cyclic voltammogram and a current Vs time trace may be extracted.   
1.6 Carboplatin and 5-Fluorouracil as chemotherapeutic agents  




 Structure of Carboplatin is shown in Figure 3. It is a common chemotherapeutic drug 
used to treat various cancer types mainly ovarian, lung, neck and head. Carboplatin was 
introduced in 1980, after the accidental discovery of anticancer properties of cisplatin, which 
was a major landmark in the history of developing effective chemotherapy drugs.32, 33 
      
Figure 3. Structure of carboplatin 
Similar to cisplatin, carboplatin belongs to the platinum based antineoplastic agents and 
interfere with DNA repair by interacting with DNA. The mechanism of carboplatin is similar to 
that of cisplatin in that it forms interstrand and intrastrand DNA crosslinks which leads to cell 
growth inhibition and apoptosis.34-36 However, carboplatin has less server side effects compared 
to cisplatin.37 Carboplatin is typically given to the patients by intravenous (IV) injections.38 
 
1.6.2    5- Fluorouracil 
Since, 1957, 5- Fluorouracil (5-FU) has been widely used as a chemotherapy drug. It 
has been used to treat colon cancer, breast cancer and other types of cancers, like neck and 
head. 5-FU is given intravenously (IV). It is a heterocyclic aromatic compound and its structure 
is similar to the structure of pyrimidine molecule of DNA and RNA. It is categorized as an 
antimetabolite which are very similar to the substances in the cell. Furthermore, it is classified 
as an analogue of uracil.39 In 5-FU, a fluorine atom is at the C-5 position in place of the 
hydrogen atom. Hence, 5-FU can incorporated in to DNA and RNA and interfere with nucleoside 
metabolism. This leads to cytotoxicity and cell death. Figure 4 shows the chemical structures of 
5-FU and Uracil. Another anticancer effect of 5-FU arises from its inhibition of thymidylate 
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synthase (TS), an enzyme that catalyzes the biosynthesis of thymidylate.40, 41 Thymidilate is 
necessary for DNA replication and repair. Hence it absence causes the cell death. 
 
Figure 4. Chemical structures of 5-fluorouracil and uracil42 
 1.7 KU-32 as a neuroprotective agent 
KU-32, developed by Dr. Brian Blagg at KU (Figure 6), is a novel novobiocin-based C-
terminal inhibitor of Hsp90 and increases the expression of Hsp70 and thereby induces a 
protective cellular heat shock response. As a neuroprotective agent, it has been found that KU-
32 is capable of preventing and reversing the diabetic peripheral neuropathy (DPN) in mice43 as 
well as protect against glucose-induced death of embryonic DRG (dorsal root ganglia) 
neurons.43 DPN is usually associated with demyelination, axonal atrophy, blunted regenerative 
potential and loss of peripheral nerve fibers.44 Moreover, Hsp90 inhibitors are being used as 
chemotherapeutic and neuroprotective agents. Its mean half-life (t½) is found to be 105.6 
minutes in plasma and 106.9 minutes in brain tissue.45  
 




1.8 Organization of this Chapter.  The Experimental Procedures and Results and Discussion 
sections of this chapter are each divided into three sections: (1) Measuring H2O2 levels in 
carboplatin treated rats, (2) Probing H2O2 levels in 5-FU treated rats, (3) Treatment of 5-FU-
treated rats with KU-32. This organization is the most logical, given that experiments with 
multiple batches of rats were accomplished. Thus, each section is indicative of the goal for each 
particular experiment. 
2. Experimental Procedures 
2.1 Experimental Procedures: (1) Measuring H2O2 levels in carboplatin treated rats 
2.1.1 Animals 
All experiments were carried out in accordance with the National Institute of Health guide 
for the care and use of laboratory animals. All the procedures were approved by the University 
of Kansas institutional Animal Care and use Committee. Experiments were carried out using 
male Wistar rats (Charles River Laboratories, Inc., Wilmington, MA, USA). Rats were housed 3 
per cage in the University of Kansas Institutional Animal Care Unit. Food and water were 
supplied at libitum. Rats were maintained on a 12 hour light / dark cycle with lights on at 6.00 
AM and lights out at 6.00 PM. A temperature of 70 ± 2 °C and a humidity level of 50 ± 20% was 
maintained. 
2.1.2 Carboplatin treatment 
Carboplatin (lot number 61703-339-50) was purchased from Hospira (Lake Forest, IL, 
USA). And Mercaptosuccinic acid was purchased from sigma Aldrich. Male wistar rats received 
one injection (IV, Tail vein) of carboplatin (30 mg/Kg) once a week for four consecutive weeks. 
All the drug solutions were made in biological saline. Both dosage and treatment regimens have 




2.1.3 Carbon fiber Micro Electrode fabrication 
Electrode fabrication was discussed in more detail in Chapter 2. Briefly, carbon-fiber 
microelectrodes were made in-house. Carbon-fibers, 7 µm in diameter, were loaded into glass 
capillaries (4 in, 1.2mm OD; A-M System, Inc. Carlsberg, WA, USA) and pulled using an 
electrode puller (Narishige International USA, East Meadow, NY, USA). Carbon-fiber tips were 
cut using a scalpel 50 µm from the end of the glass seal. Then the electrodes were sealed using 
an epoxy mixture of 0.24 grams EPI-CURE 3234 Curing Agent and 2.00 grams EPON Resin 
815C. Excess resins removed by dipping the electrodes several times in toluene.  Finally, the 
electrodes were baked for 1 hour at 100 °C. The electrodes were back filled with 0.5 M 
potassium acetate in order to establish an electrical connection. 
2.1.4 Brain slice preparation 
Rats were anesthetized by isoflurane inhalation and decapitated by Rachel Ginther. 
Then the brain was immediately removed and placed in ice-cold artificial cerebral spinal fluid 
(aCSF). The aCSF solution consist of (in mM) 126 NaCl, 2.5 KCl, 25 NaHCO3, 1.2 NaH2PO4, 2.4 
CaCl2, 1.2 MgCl2, 20 HEPES, 11 D- glucose. PH was adjusted to 7.4. aCSF solution was  
continuously saturated with 95% O2 / 5% CO2 throughout the experiment to ensure the tissue 
receives ample oxygen. 
The cerebellum was sliced with a sterilized razor blade. One hemisphere of the brain was flash 
frozen on dry ice and was stored at - 80 °C while the other hemisphere was mounted to a agar 
block using glue. 300 µm thick coronal brain slices were prepared using an NVSL vibratome 
(Leica Microsystems, Bannockburn, IL, USA). In one recording session, a single striatal brain 
slice was transferred to a perfusion chamber and submerged in oxygenated aCSF continuously 
flowing (2 mL/min) maintained at 34 °C using a thermostatted perfusion chamber and in-line 
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heater. Brain slice was allowed to equilibrate for 1 hour after transferring to the perfusion 
chamber. Then the measurements were collected. 
2.1.5 Electrochemical Measurements Using FSCV 
In a typical brain slice experiment, pre calibrated cylinder carbon-fiber microelectrodes 
were inserted using micromanipulators and a stereoscope until the tip was 100 µm below the 
surface of the brain slice. A diagram of the experimental setup is shown in Figure 6. The 
carbon-fiber working electrode was positioned between two biphasic stimulating electrodes in 
the striatum. A triangular waveform, starting at -0.4 V ramping up to 1.4 V and back to -0.4 V 
was applied to the working electrode at a scan rate of 400 V/s and an update rate of 10 Hz. An 
Ag/AgCl reference electrode was used. Dopamine (DA) release was evoked by applying a 
single biphasic pulse (350 µA, 4 ms total duration) to the stimulating electrode. First, a baseline 
DA signal was established to ensure slice viability in the striatum. A 5 minutes recovery period 
was allowed between each measurement. DA oxidation current was measured and plotted 
versus potential and the successive voltammograms were plotted against time. Same wave 
form was applied to measure H2O2. For quantification of H2O2 release, a baseline DA was 
determined to ensure the slice viability. After establishing the DA signal, 1 mM MCS 
(mercaptosuccinic acid) was introduced to the slice to elevate endogenous H2O2 levels. After 
introducing the MCS a long file was collected for 130 seconds.  Subsequent files (20 seconds) 
were collected to determine the H2O2 levels. In each color plot the back ground was subtracted 
to the minimum current. At the end of each recording session, catalase (10µM) was introduced 
to the brain slice to confirm the disappearance of the electrochemical currents, confirming the 
presence of H2O2. This procedure was followed for all the files in which MCS was used. The 
concentration of H2O2 released was determined by calibration of electrodes. The calibration 





Statistical analyses were performed using graph pad prism software (Graph pad 
software Inc., San Diego, CA, USA). n =5 number of rats. Student t test was performed (p<0.05) 
 
Figure 6. The experimental set up of a brain slice experiment. (A) Brain slice is placed in the 
perfusion chamber and a continuous acsf buffer flow is supplied. (B) Stimulating electrode and 
working electrode is placed in to the striatum  
2.2 Experimental Procedures: (2) Measuring H2O2 levels in 5-FU treated rats 
2.2.1 Animals  
All experiments were carried out using male Wistar rats (Charles River Laboratories, Inc., 
Wilmington, MA, USA). Rats were housed 3 per cage in the University of Kansas Institutional 
Animal Care Unit. Food and water were supplied at libitum. Rats were maintained on a 12 hour 
light / dark cycle with lights on at 6.00 AM and lights out at 6.00 PM. A temperature of 70 ± 2 °C 









 Pharmaceutical grade 5-Fluorouracil was purchased from Sigma Aldrich  
2.2.3 Drug treatment 
Male wistar rats received one injection (IV, Tail vein) of 5-FU (25mg/Kg) once a week for two 
consecutive weeks. All the drug solutions were made in biological saline. Both dosage and 
treatment regimens have been chosen to mimic a reasonable clinical dosing regimen and to 
allow for the drug effect to stabilize. 
2.2.4 Brain slice preparation 
H2O2 probing was performed a week after the treatments.Brain slice preparation and FSCV 
measurements were done as mentioned before.  
2.2.5 H2O2 quantification 
H2O2 levels were quantified in each rat group in a similar way to the carboplatin experiment. 
 2.2.6 Statistics  
 ANOVA with Post HOC test was used to determine statistical differences. P<0.05.  
GraphPad prism 5 (Graphpad Software, Inc, La Jolla, CA) was used for graphical and statistical 
analysis. 
2.3 Experimental Procedures: (3) Treatment of 5-FU-treated rats with KU-32 
2.3.1 Animals 
All experiments were carried out using male Wistar rats (Charles River Laboratories, 
Inc., Wilmington, MA, USA). Rats were housed 3 per cage in the University of Kansas 
Institutional Animal Care Unit. Food and water were supplied at libitum. Rats were maintained 
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on a 12 hour light / dark cycle with lights on at 6.00 AM and lights out at 6.00 PM. A temperature 
of 70 ± 2 °C and a humidity level of 50 ± 20% were maintained. 
2.3.2 Drugs 
 All chemotherapeutic agents were purchased from Sigma Aldrich and KU32 was 
supplied by Dr. Blagg research group at Department of Medicinal Chemistry at the University of 
Kansas. 
2.3.3 Drug treatment 
 Male wistar rats received one injection (IV, Tail vein) of 5FU (30 mg/Kg) and (20mg/Kg) 
once a week for four consecutive weeks. For the combination treatment, rats were administered 
5FU (20 mg/Kg) IV, Tail vein. On the same day KU32 was administered via oral gavage route 
(20 mL/Kg). All the drug solutions were made in biological saline. Both dosage and treatment 
regimens have been chosen to mimic reasonable clinical dosing regimens and to allow for the 
drug effect to stabilize. 
2.3.4 Brain slice preparation 
 H2O2 probing was performed 2 weeks after the treatments. Brain slice preparation and 
FSCV measurements were done as mentioned before.  
2.3.5 H2O2 quantification 
 H2O2 levels were quantified in each rat group in a similar way to the carboplatin 
experiment. 
2.3.6 Statistics  
 2 way ANOVA was used to determine statistical differences. P< 0.05.  GraphPad prism 5 
(Graphpad Software, Inc, La Jolla, CA) was used for graphical and statistical analysis. 
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All the chemotherapy treatments were carried out by Rachel Ginther. 
 
3. Results and Discussion 
3.1 (1) Measuring H2O2 levels in carboplatin treated rats  
A representative file for H2O2 measurement after MCS treatment is shown in Figure 7. Each 
peak was recorded and averaged across all of the files to determine the overall H2O2 levels. As 
the release is spontaneous, several sample analyses showed multiple peaks corresponding to 
release events. H2O2 levels were elevated upon the addition of 1 mM MCS. As was mentioned,  
 
Figure 7. Schematic diagram which shows spontaneous release of H2O2 in rat striatal brain slice 
after inhibition of glutathione peroxidase with MCS. (A) Current plot (B) Representative color 
plot. (C) cyclic voltammogram of H2O2. 
 
MCS is an efficient inhibitor of glutathione peroxidase, an antioxidant enzyme that catalyzes the 
decomposition of H2O2 to water. Addition of MCS prevents this decomposition, thereby 
1 µM 
5 s 






enhancing endogenous H2O2 levels.
17, 18 Detected peroxide levels were greater in carboplatin 
treated rats compared to the saline treated rats as shown in Figure 8 (t-test p <0.05, n = 5). 
Hence, these data indicated a high free radical activity in chemotherapy treated rats. 
Figure 8.  H2O2 levels are greater in carboplatin treated rats compared to vehicle treated rats. 
*P<0.05 (t-test, carboplatin n = 5, vehicle n = 5).   
  
 These results suggests that carboplatin treatment results in an increase of H2O2 levels that 
persists at least one week after the last injection (rats underwent neurochemical analysis at this 
time). This enhanced production could have several long-term consequences. Given that H2O2 
is a reactive oxygen species, neuronal dysfunction could result directly from chemical oxidative 
damage. Additionally, H2O2 has been shown to elicit an immune response, thereby activating 
biochemical pathways that result in the production of inflammatory cytokines, such as tumor 
necrosis factor alpha (TNFα).46 Elevated TNFα levels, induced by ROS production, have 
already been implicated in post-chemotherapy cognitive impairment (PCCI) associated with 
doxorubin chemotherapy,46 which is often used to treat breast cancer.46, 47 Also H2O2 is a 
neuromodulator in the DA pathway. This increased endogenous H2O2 levels can affect DA 
release and uptake causing cognitive dysfunction.48 Finally, as alluded to earlier in this chapter, 







3.2 (2) Measuring H2O2 levels in 5FU treated rats  
A representative file for H2O2 release following 5FU treatment is shown in Figure 9. An 
increased oxidation current was observed for the H2O2 in 5FU treated rats compared to the 
vehicle treated. The detected peroxide levels were 151% greater in 5FU treated group than the 
vehicle treated group (5FU n = 5, Vehicle n = 3, ANOVA p<0.05)(Figure 10). Upon the 
introduction of MCS the current generated was enhanced. Disappearance of oxidation current 
after the introduction of 1 U/ml catalase verified that the observed current was due to the 
oxidation of H2O2 (Figure 11). These data suggest that free radical activity is greater in 5FU 









Figure 9. Spontaneous release of H2O2 in rat striatal brain slice after inhibition of glutathione 
peroxidase with MCS; (A) Current Plot, (B) Representative color plot, and (C) cyclic 

















Figure 10.Enhanced levels of H2O2 in brain slices from 5-FU treated rats. *P< 0.05 (ANOVA with 
post hoc test, treated n=5, vehicle n=3). 
 
Figure 11. Cyclic voltammograms obtained before introducing catalase and after introducing 
catalase (Enzymatic degradation of H2O2). Oxidation current for H2O2 decreased upon addition 
of 1U/ml catalase Fig (12). About 15 minutes after the introduction of catalase, the oxidation 
current obtained for H2O2 was further diminished, suggesting that the current was due to 





catalase at 5 min 























3.3 (3) Treatment of 5FU-treated rats with KU-32 
To determine the effect of KU-32 on the spontaneous release of H2O2, three treatment groups 
(Saline , 5FU, 5FU+KU32) were compared. Results from multiple rats are shown in Figure 12. 
H2O2 levels in 5FU treated rats were significantly increased compared to vehicle treated and 
5FU+KU32 treated rats (n=5, 5FU+KU32 n=3, vehicle n=5, Two way ANOVA with post hoc test, 
P < 0.05). These results suggest that treatment with 5-FU results in enhanced levels of H2O2 
and that KU-32 brings levels back to normal. However, it is not yet clear whether 5-FU 
decreases the production of H2O2 or diminishes the antioxidant capacity of the brain. On the 
other hand, KU-32 is known to induce the heat shock response and upregulate proteins that are 
protective to cells. These proteins likely include those which serve an antioxidant role. 
Nevertheless, additional work will be required to determine specifically which proteins are 
upregulated and to what extent in the 5-FU chemo brain model.  
 
Figure 12. KU-32 restored H2O2 levels to normal in 5FU treated rats.  *P < 0.05 (two-way 

















These data revealed that peroxide levels are greater in chemotherapy treated rats compared to 
the vehicle treated rats. As discussed, H2O2 may have a number of deleterious effects on 
neuronal function including oxidative damage, inflammation, and neuromodulation. Because 
dopamine’s multiple roles as a neurotransmitter, reward,49 cognition,50 locomotion, and 
behavior
50, 51
 may all be affected. Studies done in our group have revealed that DA uptake and 
release is impaired in chemotherapy treated rats,
15 
suggesting that increased H2O2 levels are a 
contributing factor in post chemotherapy cognitive impairment. Furthermore, combination of 5-
FU with KU-32 which is a neuroprotective agent has suppressed the elevated H2O2 levels, 
reversing the neuronal degeneration and replacing the proper function of neurons. KU 32 is an 
inhibitor of Hsp90 heat shock protein which can increase the expression of Hsp70. Researchers 
think that enhancement in Hsp70 expression may inhibit neuronal degeneration and improve the 
proper function of neurons.52 
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Conclusions and future directions 
1.1 Novel GO/Nafion CFME Conclusions 
Our novel modified carbon fiber microelectrode exhibited 5.3-fold enhancement in 
oxidation current of H2O2. Surface characterization done with Scanning Electron Microscopy 
and Energy Dispersive X- ray Spectroscopy confirmed the thin surface coating of GO and 
Nafion on the carbon fiber .  Electrochemical behavior of the modified electrode was very similar 
to that of bare carbon fiber micro electrode. Limit of detection (LOD) for the GO/Nafion CFME 
was found to be 0.05 µM. Detection limit for the bare carbon fiber micro electrode is found to be 
2 µM by Sanford and coworkers.1 It revealed an enhancement in the sensitivity compared to the 
bare CFME. Moreover, a modified electrode was successfully used in brain slice experiments to 
probe H2O2 levels. A modified electrode was used to record the oxidation of H2O2 in brain slices. 
It demonstrated a similar electrochemical behavior compared to the bare carbon fiber micro 
electrode. This work shows that unique characteristics of graphene oxide make it a promising 
material for microelectrode modifications. In the future, this modified sensor can be used to 
detect other electroactive species as well. Moreover, in addition to Nafion, other electroactive 
polymers can be used for the modification to selectively detect other electro active species. 
However, one drawback is that the stability and the selectivity of the modified electrode depend 
on the integrity of the coating. 
 
1.2 PCCI conclusions and future directions. 
Previous studies done in our group have revealed that DA release and uptake   
attenuated in chemotherapy treated rats. Our hypothesis was that enhanced free radical activity 
due to the mitochondrial dysfunction can cause neuronal degeneration causing PCCI. Hydrogen 
peroxide is an important membrane permeable ROS which plays an  important role in the 
63 
 
dopaminergic pathway. Interestingly, our data revealed that H2O2 release is significantly 
increased in brain slices from chemotherapy treated rats. Hence, the mechanism of PCCI can 
be a consequence of neuronal degeneration induced by enhanced free radical activity. 
Behavioral studies done by our collaborator (Dr. David. P. Jarmolowicz), further confirmed our 
results.   In addition, neuro-protecting agent (KU-32) suppressed the elevated H2O2 levels. 
However, more investigations are required including studies on demyelination to assess the role 
of H2O2 on the onset of post chemotherapy cognitive impairment. Chemotherapy drugs can 
inhibit neuronal signaling by affecting myelination.2 Therefore it is important to investigate how 
chemotherapy can affect myelination. Also it is important to utilize more complex and rigorous 
behavioral paradigms in future studies. Furthermore, Fluorescence imaging of H2O2 in the MSN 
can be used to investigate its role in PCCI. There are several fluorescent dyes including 
Redoxfluor-1 (RF1) which can be used. Images can be acquired using a cascade CCD camera.3 
Using this method intracellular H2O2 levels can be directly visualized. 
          Moreover, a variety of chemotherapeutic agents including blood brain barrier permeable 
and impermeable, are currently been used in clinic are causing chemo brain. It is important to 
investigate the extent of free radical activity for each type of chemotherapeutic agent to have a 
better understanding. 
In the future it would be interesting to probe H2O2 levels in Zebrafish whole brain which 
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